TickerFactsScreenerDevelopers

ALNYLAM PHARMACEUTICALS, INC. (ALNY) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2017: $02018: $1.80M2019: $25.06M2020: $74.19M2021: $115.00M2022: $140.17M2023: $268.22M2024: $306.51M2025: $677.17M$677.17M
2017Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$677.17M+120.9%
2024$306.51M+14.3%
2023$268.22M+91.3%
2022$140.17M+21.9%
2021$115.00M+55.0%
2020$74.19M+196.0%
2019$25.06M+1290.8%
2018$1.80M—
2017$0—